Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
60
PBH Quote, Financials, Valuation and Earnings
Last price:
$62.39
Seasonality move
:
4.54%
Day range:
$62.24 - $63.03
52-week range:
$57.25 - $90.04
Dividend yield:
0%
P/E ratio:
15.46x
P/S ratio:
2.79x
P/B ratio:
1.64x
Volume:
340.2K
Avg. volume:
460K
1-year change:
-20.68%
Market cap:
$3B
Revenue:
$1.1B
EPS (TTM):
$4.03
Analysts' Opinion
-
Consensus RatingPrestige Consumer Healthcare, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $78.00, Prestige Consumer Healthcare, Inc. has an estimated upside of 25.18% from its current price of $62.31.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $70.00 representing 100% downside risk from its current price of $62.31.
Fair Value
-
According to the consensus of 6 analysts, Prestige Consumer Healthcare, Inc. has 25.18% upside to fair value with a price target of $78.00 per share.
PBH vs. S&P 500
-
Over the past 5 trading days, Prestige Consumer Healthcare, Inc. has underperformed the S&P 500 by -0.82% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Prestige Consumer Healthcare, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Prestige Consumer Healthcare, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Prestige Consumer Healthcare, Inc. reported revenues of $274.1M.
Earnings Growth
-
Prestige Consumer Healthcare, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Prestige Consumer Healthcare, Inc. reported earnings per share of $0.86.
Enterprise value:
3.9B
EV / Invested capital:
1.37x
Price / LTM sales:
2.79x
EV / EBIT:
11.38x
EV / Revenue:
3.53x
PEG ratio (5yr expected):
3.28x
EV / Free cash flow:
15.34x
Price / Operating cash flow:
12.14x
Enterprise value / EBITDA:
10.48x
Gross Profit (TTM):
$602.6M
Return On Assets:
5.92%
Net Income Margin (TTM):
18.09%
Return On Equity:
11.11%
Return On Invested Capital:
7.05%
Operating Margin:
29.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.1B | $1.1B | $1.1B | $283.8M | $274.1M | |
| Gross Profit | $595.4M | $590.6M | $602.6M | $151.8M | $146.4M | |
| Operating Income | $349.8M | $325.4M | $344.3M | $84.3M | $79.7M | |
| EBITDA | $387.2M | $356.9M | $373.7M | $92.3M | $87.3M | |
| Diluted EPS | -$1.66 | $4.11 | $4.03 | $1.09 | $0.86 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $304.8M | $336.7M | $388.2M | $380.7M | $497.4M | |
| Total Assets | $3.7B | $3.7B | $3.3B | $3.3B | $3.4B | |
| Current Liabilities | $148.9M | $152.3M | $129.7M | $106.9M | $134.6M | |
| Total Liabilities | $2.2B | $2.1B | $1.8B | $1.6B | $1.6B | |
| Total Equity | $1.5B | $1.6B | $1.5B | $1.7B | $1.8B | |
| Total Debt | $1.6B | $1.5B | $1.3B | $1.1B | $1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $224.5M | $263M | $263.4M | $69.8M | $57.5M | |
| Cash From Investing | -$8.8M | -$23.7M | -$18.2M | -$2M | -$2.9M | |
| Cash From Financing | -$198.2M | -$250M | -$176.6M | -$51.2M | -$74.9M | |
| Free Cash Flow | $215.7M | $254.6M | $255.5M | $67.8M | $55.4M | |
PBH
Sector
Market Cap
$3B
$28.1M
Price % of 52-Week High
69.2%
51.39%
Dividend Yield
0%
0%
Shareholder Yield
4.02%
-1.49%
1-Year Price Total Return
-20.69%
-17.13%
Beta (5-Year)
0.389
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$61.99
200-day SMA
Sell
Level
$72.57
Bollinger Bands (100)
Sell
Level
59.86 - 66.06
Chaikin Money Flow
Buy
Level
88.7K
20-day SMA
Buy
Level
$60.86
Relative Strength Index (RSI14)
Buy
Level
58.44
ADX Line
Buy
Level
16.54
Williams %R
Sell
Level
-18.75
50-day SMA
Buy
Level
$60.79
MACD (12, 26)
Buy
Level
15.36
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Sell
Level
-1.3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.9876)
Buy
CA Score
(Annual)
Level (0.1842)
Buy
Beneish M-Score
(Annual)
Level (-2.3826)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.6731)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American OTC Healthcare segment consists of BC and Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve. The International OTC Healthcare segment includes Fess and Hydralite. The company was founded in 1996 and is headquartered in Tarrytown, NY.
Stock Forecast FAQ
In the current month, PBH has received 5 Buy ratings 1 Hold ratings, and 0 Sell ratings. The PBH average analyst price target in the past 3 months is $78.00.
-
Where Will Prestige Consumer Healthcare, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Prestige Consumer Healthcare, Inc. share price will rise to $78.00 per share over the next 12 months.
-
What Do Analysts Say About Prestige Consumer Healthcare, Inc.?
Analysts are divided on their view about Prestige Consumer Healthcare, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Prestige Consumer Healthcare, Inc. is a Sell and believe this share price will drop from its current level to $70.00.
-
What Is Prestige Consumer Healthcare, Inc.'s Price Target?
The price target for Prestige Consumer Healthcare, Inc. over the next 1-year time period is forecast to be $78.00 according to 6 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is PBH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Prestige Consumer Healthcare, Inc. is a Buy. 5 of 6 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of PBH?
You can purchase shares of Prestige Consumer Healthcare, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Prestige Consumer Healthcare, Inc. shares.
-
What Is The Prestige Consumer Healthcare, Inc. Share Price Today?
Prestige Consumer Healthcare, Inc. was last trading at $62.39 per share. This represents the most recent stock quote for Prestige Consumer Healthcare, Inc.. Yesterday, Prestige Consumer Healthcare, Inc. closed at $62.31 per share.
-
How To Buy Prestige Consumer Healthcare, Inc. Stock Online?
In order to purchase Prestige Consumer Healthcare, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get PBH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PBH
Sector
P/E ratio
15.46x
23.89x
PEG ratio
3.28x
-0.01x
P/B ratio
1.64x
1.81x
Price / LTM sales
2.79x
1.59x
Growth Metrics
PBH
Sector
Revenue growth
-3.41%
4.62%
Earnings growth
-21.22%
11.06%
Revenue (5-year growth)
3.39%
6.5%
Earnings forecast
$0.97
-$0.21
Profitability
PBH
Sector
Profitability FY 2024
$613.2M
$3.6M
Return on invested capital
7.05%
-31.84%
Return on assets
5.92%
-27.96%
Return on equity
11.11%
-37.63%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Feb
5
Balance Sheet
PBH
Sector
Total cash
$119.1M
$26.4M
Short term investments
--
$25.7M
Total assets
$3.5B
$76.9M
Long term debt
$1B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
Sell
32
SMX alert for Dec 24
SMX (Security Matters) Plc [SMX] is down 8.94% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
